Co-Authors
This is a "connection" page, showing publications co-authored by XIFENG WU and HUA ZHAO.
Connection Strength
2.296
-
Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer. 2007 May 15; 120(10):2208-13.
Score: 0.298
-
Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology. 2005 Oct; 66(4):769-74.
Score: 0.266
-
Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5.
Score: 0.262
-
Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7.
Score: 0.221
-
Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog. 2002 Feb; 33(2):99-104.
Score: 0.207
-
Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008 Dec 01; 14(23):7956-62.
Score: 0.083
-
Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22.
Score: 0.075
-
Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9.
Score: 0.073
-
Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):441-7.
Score: 0.068
-
A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6.
Score: 0.065
-
Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis. 2005 Oct; 26(10):1741-7.
Score: 0.065
-
An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005 Apr 04; 582(1-2):71-8.
Score: 0.064
-
Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1408-15.
Score: 0.064
-
Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57.
Score: 0.063
-
Genetic susceptibility to tobacco-related cancer. Oncogene. 2004 Aug 23; 23(38):6500-23.
Score: 0.062
-
Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95.
Score: 0.061
-
Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
Score: 0.057
-
Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2003 Aug 15; 9(9):3356-61.
Score: 0.057
-
An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7.
Score: 0.056
-
XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9.
Score: 0.056
-
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
Score: 0.053
-
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer. 2007 Aug 01; 110(3):534-42.
Score: 0.019